Skip To Main Content
Xiang Yin on Muck Rack

Xiang Yin

As seen in: Color Research & Application, Nature, Wiley Online Library, arXiv, ScienceDirect, Frontiers, MDPI, Taylor & Francis Online, ACS Publications, Royal Society of Chemistry and
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Xiang

Contact Xiang, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Practical lessons in the global scaling of clinical AI: from one hospital to over a million patients screened

|
By Richa Tiwari, Rajroshan Sawhney, Kasumi Widner, Kim Ramasamy, Ravindran Padmanabhan, Paisan Ruamviboonsuk, Angus W. Turner, Jay Nayar, Jessica Williams, Naama Hammel, Xiang Yin, Theo Guidroz, Dave Watson, Jonathan Krause Verified, Quang Duong, Yun Liu, Yossi Matias, Ronit Levavi Morad, Avinatan Hassidim, Dale Webster, Sunny Virmani
| Nature Verified
Scaling a successful deep learning tool across three highly distinct settings – in India, Thailand and Australia — offers cross-cutting insights that may inform the expansion of healthcare artificial intelligence globally.
Open in Who Shared Issue with article?

Integrated medical and elderly care utilisation and outcomes in China: insights from a mixed-methods configurational analysis

|
By Ziyu Li, Chao Cao, Xiang Yin
| Taylor & Francis Online
Abstract Introduction While establishing integrated medical and older-adult care systems has been widely adopted as a crucial strategy to address population ageing, little is known about either the configurations that facilitate integrated care service utilisation or the actual policy outcomes in enhancing healthy ageing levels. Theory Conceptualising the implementation of China’s integrated medical and elderly care policy as a strategic action field.
Open in Who Shared Issue with article?

Comparison of obecabtagene autoleucel versus an external control arm in adult patients with relapsed/refractory B-cell acute lymphoblastic leukemia

|
By Max S. Topp, Bijal Shah, Elias Jabbour, Jae Park, Paul W. Shaughnessy, Aaron Logan, Karamjeet S. Sandhu, Mehrdad Abedi, Michael Bishop, Daniel DeAngelo, Xiang Yin, Ruthanna Davi, Katharine A. Hodby, Ram Malladi, Wolfram Brugger, Claire Roddie, Hagop Kantarjian, Justin Shang
| Nature Verified
Abstract In the single-arm Phase Ib/II FELIX study (NCT04404660), obecabtagene autoleucel (obe-cel; CD19-directed autologous CAR T-cell therapy) demonstrated high overall remission rates (ORR) and a favorable safety profile in adults with relapsed/refractory (R/R) B-cell acute lymphoblastic leukemia (B-ALL). To contextualize results from FELIX, we compared the efficacy and safety of obe-cel with matched external control arms (ECA) derived from historical trials using propensity score matching.
Open in Who Shared Issue with article?
See all 41 licensed articles (42 Total)